Bioprosthetic valve oversizing is associated with increased risk of valve thrombosis following TAVR.
Timothy F SimpsonCraig V TuohyKatherine RajotteHarsh GolwalaCristina FussHoward K SongFiras E ZahrScott M ChadderdonPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2020)
In this pragmatic study of patients undergoing TAVR with SAPIEN 3 valves, we report the novel finding that oversizing by more than 20% was independently associated with increased risk of HALT. These findings warrant confirmation in larger and prospective trials.